Pilot multi-centre randomised trial of the impact of pre-operative focused cardiac ultrasound on mortality and morbidity in patients having surgery for femoral neck fractures (ECHONOF-2 pilot) by Canty, D. J. et al.
VU Research Portal
Pilot multi-centre randomised trial of the impact of pre-operative focused cardiac
ultrasound on mortality and morbidity in patients having surgery for femoral neck
fractures (ECHONOF-2 pilot)
Canty, D. J.; Heiberg, J.; Yang, Y.; Royse, A. G.; Margale, S.; Nanjappa, N.; Scott, D.;




DOI (link to publisher)
10.1111/anae.14130
document version
Publisher's PDF, also known as Version of record
document license
Article 25fa Dutch Copyright Act
Link to publication in VU Research Portal
citation for published version (APA)
Canty, D. J., Heiberg, J., Yang, Y., Royse, A. G., Margale, S., Nanjappa, N., Scott, D., Maier, A., Sessler, D. I.,
Chuan, A., Palmer, A., Bucknill, A., French, C., & Royse, C. F. (2018). Pilot multi-centre randomised trial of the
impact of pre-operative focused cardiac ultrasound on mortality and morbidity in patients having surgery for
femoral neck fractures (ECHONOF-2 pilot). Anaesthesia, 73(4), 428-437. https://doi.org/10.1111/anae.14130
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            • Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
            • You may not further distribute the material or use it for any profit-making activity or commercial gain
            • You may freely distribute the URL identifying the publication in the public portal ?
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
E-mail address:
vuresearchportal.ub@vu.nl
Download date: 27. May. 2021
Original Article
Pilot multi-centre randomised trial of the impact of pre-operative
focused cardiac ultrasound on mortality and morbidity in patients
having surgery for femoral neck fractures (ECHONOF-2 pilot)
D. J. Canty,1,2 J. Heiberg,3,4 Y. Yang,5,6 A. G. Royse,7,8 S. Margale,9,10 N. Nanjappa,11,12 D. Scott,13,14
A. Maier,15,16 D. I. Sessler,17 A. Chuan,18,19 A. Palmer,20 A. Bucknill,21,22 C. French23 and C. F. Royse23,24
1 Senior Lecturer and Director of Ultrasound Simulation, 5 Clinical Senior Lecturer, 7 Professor and Co-director of the
Ultrasound Education Group, 13 Professor, School of Medicine, 22 Clinical Associate Professor, Department of Surgery,
University of Melbourne, Australia
2 Consultant Anaesthetist, Royal Melbourne and Monash Hospitals, Melbourne, Australia
3 Research Fellow, 24 Consultant Anaesthetist, Department of Anesthesia and Pain Management, 8 Consultant
Cardiothoracic Surgeon, Department of Cardiothoracic Surgery, 21 Head of Orthopaedics, Royal Melbourne Hospital,
Melbourne, Australia
4 Anesthetic Registrar, Department of Anesthesia and Intensive Care, Aarhus University Hospital, Aarhus, Denmark
6 Consultant Intensivist, Department of Intensive Care, Western Health, Melbourne, Australia
9 Senior Lecturer, Northside Clinical School, University of Queensland, Brisbane, Australia
10 Consultant Anaesthetist, Department of Anaesthesia and Perfusion services, The Prince Charles Hospital, Brisbane,
Australia
11 Conjoint Senior Lecturer, University of Adelaide, Adelaide, Australia
12 Consultant Anaesthetist, Queen Elizabeth Hospital, Adelaide, Australia
14 Director of Anaesthesia and Acute Pain Medicine, St. Vincent’s Hospital Melbourne, Australia
15 Professor of Aging, Department of Medicine and Aged Care, Royal Melbourne Hospital, University of Melbourne,
Melbourne, Australia
16 Professor, Department of Human Movement Sciences, MOVE Research Institute Amsterdam, Vrije Universiteit,
Amsterdam, the Netherlands
17 Michael Cudahy Professor and Chair Department of Outcomes Research, Anesthesiology Institute, Cleveland Clinic,
OH, USA
18 Conjoint Senior Lecturer, University of New South Wales, Sydney, Australia
19 Consultant Anaesthetist, Liverpool Hospital, Sydney, Australia
20 Founding Chair, Health Economics Research Unit, Menzies Institute for Medical Research, University of Tasmania,
Hobart, Australia
23 Consultant Intensivist, Department of Intensive Care, Western Health, Melbourne, Australia
Summary
Hip fracture surgery is common, usually occurs in elderly patients who have multiple comorbidities, and is associated
with high morbidity and mortality. Pre-operative focused cardiac ultrasound can alter diagnosis and management,
but its impact on outcome remains uncertain. This pilot study assessed feasibility and group separation for a pro-
posed large randomised clinical trial of the impact of pre-operative focused cardiac ultrasound on patient outcome
after hip fracture surgery. Adult patients requiring hip fracture surgery in four teaching hospitals in Australia were
randomly allocated to receive focused cardiac ultrasound before surgery or not. The primary composite outcome was
any death, acute kidney injury, non-fatal myocardial infarction, cerebrovascular accident, pulmonary embolism or
cardiopulmonary arrest within 30 days of surgery. Of the 175 patients screened, 100 were included as trial
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participants (screening:recruitment ratio 1.7:1), 49 in the ultrasound group and 51 as controls. There was one proto-
col failure among those recruited. The primary composite outcome occurred in seven of the ultrasound group
patients and 12 of the control group patients (relative group separation 39%). Death, acute kidney injury and cere-
brovascular accident were recorded, but no cases of myocardial infarction, pulmonary embolism or cardiopulmonary
arrest ocurred. Focused cardiac ultrasound altered the management of 17 participants, suggesting an effect mecha-
nism. This pilot study demonstrated that enrolment and the protocol are feasible, that the primary composite out-
come is appropriate, and that there is a treatment effect favouring focused cardiac ultrasound – and therefore
supports a large randomised clinical trial.
.................................................................................................................................................................
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Introduction
Hip fracture patients are typically elderly and suffer
from multiple comorbid diseases. Despite advances in
healthcare, both 30-day and 1-year postoperative mor-
tality remain high at 7.1% (England and Wales) [1]
and 20–35% (Europe) [2], respectively. Death most
commonly results from comorbidities rather than the
hip fracture. Postoperative morbidity is common, often
disabling, and can require prolonged, expensive institu-
tionalisation. Prolonged longevity suggests that the
annual incidence of hip fracture worldwide could rise
from 2.3 million currently to 6.3 million by 2050 [3].
Adequate pre-operative assessment is prudent in
patients who are at high risk of cardiac disease [4].
However, there is also evidence that delaying surgery
increases postoperative mortality [5–7], constraining
the time available for pre-operative investigations. Clin-
ical assessment of cardiac disease is unreliable, misdiag-
nosing significant cardiovascular disease in about half
of all patients [8–10]. Transthoracic echocardiography
is a non-invasive investigation that identifies structural
cardiac pathologies independently associated with post-
operative mortality, such as cardiac failure [11], aortic
stenosis [12] and pulmonary hypertension [13].
Transthoracic echocardiography also identifies abnor-
mal haemodynamic states, including hypovolaemia,
cardiac failure and vasodilation [14], allowing rapid
correction of these before anaesthesia and surgery.
However, formal echocardiographic evaluation by
cardiologists may not be routinely available in the short
period required available before timely surgery [15].
Focused cardiac ultrasound is a goal-directed, abbrevi-
ated form of echocardiography, which enhances bed-side
clinical assessment and guides acute medical decisions
[16]. Without delaying surgery, focused cardiac ultra-
sound promotes diagnostic accuracy, often changing
diagnosis and management [8, 17], for example, by guid-
ing pre-operative intravascular volume replacement, and
rationalising the use of invasive monitoring, vasopressor
infusions and planned postoperative intensive care.
In a two-centre retrospective cohort analysis of hip
fracture patients, the use of ultrasound was associated
with a three-fold reduction in 30-day mortality, com-
pared with a control group with similar risk factors
[8]. This pilot study aims to inform the feasibility of
conducting a larger multi-centre, prospective ran-
domised controlled trial, to test the hypothesis that
compared with controls, focused cardiac ultrasound
alters the medical management of hip fracture patients
and reduces a collapsed composite of serious complica-
tions and mortality 30 days after surgery.
Methods
This parallel group, randomised, controlled, multi-
centre pilot study with 1:1 allocation ratio was approved
by the Melbourne Health Research Ethics Committee.
Written consent was obtained from all participants or
next of kin with power of attorney.
Themain research site was ametropolitan tertiary uni-
versity hospital with a high volume of acute orthopaedic
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surgery and sufficient clinicians proficient in focused car-
diac ultrasound. Three similar centres participated in
recruitment at varying times during the study period. The
trial did not have per-participant funding which reduced
the potential recruitment to days when researchers were
available, and for some institutions, a limited duration of
recruitment.
Adult participants were eligible for inclusion if
they were scheduled for surgical repair of unilateral
fractured neck of femur (fracture between the femoral
head and a line 5 cm below the lesser trochanter). Par-
ticipants were not studied if they had received previous
hip surgery on the affected side, were scheduled to
receive surgery for other injuries, had metastatic cancer
or a suspected pathological hip fracture, were not
expected to survive longer than 24 h, had undergone
echocardiography within one month of the current
surgery or had received a request for echocardiography
before recruitment and random allocation in the study.
Research personnel monitored the emergency sur-
gery operating theatre list for patients scheduled for
hip fracture surgery. Potential participants were then
screened for eligibility by review of their medical notes
and bed-side assessment. After written informed con-
sent, eligible participants were randomly allocated to
either receive pre-operative focused cardiac ultrasound
(ultrasound group) or not to receive pre-operative
focused cardiac ultrasound (control group). The
screening researcher opened a sealed opaque envelope
to reveal the group allocation, which was produced by
computer-generated random number software (https://
www.randomizer.org/) arranged by a non-investigator
and hidden from research personnel until outcome
data was obtained.
Participants in the ultrasound group received
focused cardiac ultrasound within 24 h of planned sur-
gery. The written ultrasound report (Appendix S1) was
placed in a sealed envelope. At the time of surgery, the
anaesthetist completed a diagnosis and management
plan on a research form after their standard clinical
assessment, which included their usual patient history
and physical examination and review of the medical
record and results of investigations. The anaesthetist
then reviewed the concealed ultrasound report, before
repeating their diagnosis and management plan. This
allowed the research team to determine the influence,
if any, on diagnosis and management influenced by
the ultrasound findings. The ultrasound report was
replaced in the opaque envelope and sealed, to blind
researchers to the findings of the ultrasound. This is
partial blinding as the peri-operative staff could pass
on the ultrasound information to other members of
the treating team and the group allocation was not
concealed from the research nurses who performed
patient recruitment, randomisation and outcome data
collection.
Participants in the control group did not receive
ultrasound but the anaesthetist was still requested to
complete the same diagnosis and management forms.
Control group participants were not prohibited by the
study protocol from having additional investigations
after randomisation, including conventional echocar-
diography.
Focused cardiac ultrasound was performed by
trained clinicians according to the iHeartScanTM pro-
tocol (haemodynamic echocardiography assessment in
real time, Ultrasound Education Group, Department
of Surgery, University of Melbourne, VIC, Australia)
[18], and who fulfilled the criteria for training in
goal-focused cardiac ultrasound from the Australian
and New Zealand College of Anaesthetists profes-
sional recommendations [19]. This protocol uses pat-
tern recognition of two-dimensional and colour flow
Doppler images, to identify clinically important car-
diac pathology, defined as: either left ventricular
(LV) systolic or diastolic dysfunction, right ventricu-
lar (RV) systolic dysfunction, moderate or severe
valve stenosis or regurgitation [20, 21], or pericardial
effusion of greater than 0.5 cm. Left ventricular sys-
tolic dysfunction was defined as systolic fractional
reduction in LV internal dimension less than 24% or
a reduction in LV end diastolic area less than 50%.
Left ventricular diastolic dysfunction was defined as
normal LV systolic function with raised left atrial
pressure determined by the presence of a fixed curva-
ture of the interatrial septum towards the right atrium,
as demonstrated by Haji et al. [22]. Right ventricular
dysfunction was defined using ultrasound as dilation
of the RV end-diastolic area to greater than two-thirds
of the LV end-diastolic area and reduced RV free wall
motion with or without flattening of the interventric-
ular septum. The haemodynamic state was assessed
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with ultrasound by categorisation into normal, empty,
vasodilated, LV systolic and/or diastolic failure, or RV
failure, as described previously [14] using the assess-
ment of LV and RV volume and contractility, and
movement and position of the interatrial septum.
Clinically insignificant findings included mild valvular
stenosis or regurgitation, or mild reduction in systolic
ventricular function.
There were no guidelines or restrictions on the
peri-operative management of participants in the study
by anaesthetists.
In all four participating hospitals, surgery is typi-
cally undertaken within 48 h of hospital admission
after hip fracture. Participants in both groups received
review and management by internal medicine or
orthogeriatricians as early as practicable during their
hospital stay.
The feasibility outcomes of this one-year pilot
study were: to achieve a screening: recruitment ratio
below 4:1; to quantify the protocol failure rate; to
recruit at least one participant per site per week; to
achieve group separation for the primary outcome of
≥ 20%; to determine whether ultrasound delayed sur-
gery; to assess barriers to recruitment/site activation; to
achieve ≥ 25% change in cardiac diagnosis and clinical
management in participants undergoing ultrasound
compared with controls; and to determine a sample
size in the main study based on primary outcome
effect size, recruitment ratio and protocol failure rates.
The primary outcome of the proposed trial is a
30-day postoperative composite outcome of all-cause
death, acute kidney injury [23] and cardiovascular mor-
bidity (non-fatal myocardial infarction, stroke, pul-
monary embolism or cardiac arrest [24]). Definitions of
component outcomes are from the European Society of
Anaesthesiologist’s and Intensive Care Medicine joint
taskforce on peri-operative outcome measures [25] and
are shown in Appendix S2. Research nurses obtained
the morbidity and mortality data from the hospital
records, general practitioner and the medical residential
facility where required. The cause of death was obtained
from the death certificates. These outcomes were
assessed by the principal researcher from the data col-
lected by the research nurses, and by review of discharge
summaries or case notes as required. A second clinician
blinded to allocation performed primary outcome data
verification; if there was disagreement, a third blinded
reviewer would adjudicate outcome. In the definitive
pragmatic trial there will be an independent data moni-
toring team of clinicians to adjudicate morbid end-
points. The pre-operative comorbidities were obtained
from the medical record (including the pre-operative
assessment from the treating anaesthetist) and recorded
by the research nurses.
The secondary outcomes of the proposed trial are
shown in Appendix S2.
Results
Recruitment occurred between 1 February and 26
December 2016 at the primary study site, with four
other sites activated during this time-period. One site
did not recruit participants, as activation occurred just
before conclusion of recruitment for the pilot study
(Table 1). The mean (SD) screening: recruitment ratio
was 1.7 (0.2), and all sites recruited at least one partic-
ipant per week. There was one protocol violation
where a participant randomly allocated to the ultra-
sound group did not receive ultrasound before surgery
due to unavailability of suitable personnel; the partici-
pant remained in the ultrasound group on an intention-
to-treat basis. After random allocation, two participants
were not studied as the participants were subsequently












Royal Melbourne 47 110 2.3 59 1.3 1.9:1
Western General 18 37 2.1 23 1.3 1.6:1
Prince Charles 6 21 3.5 15 2.5 1.4:1
Queen Elizabeth 2 7 3.5 5 2.5 1.4:1
Total 47 175 3.7 102 2.2 1.7:1
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Assessed for 
eligibility
(n = 175 )
Randomised
(n = 102)
Not included (n = 73)
- Did not meet inclusion criteria (73)
- No consent (36)
- Additional surgery (7)
- Re-do surgery (2)
- Not neck of femur fracture (4)
- Echocardiography within one month (7)
- Team requested preoperative TTE (1)
- Ultrasound not available (2)
- In another research study (3)
- Surgery delayed >48 h (3)
- Surgery cancelled (2)
- Not enough time to recruit (1)





intervention (n = 49)
(1 participant did not receive 






intervention (n = 52)
Lost to follow-up (n = 0) 
Complete data recorded
30 days 100% (n = 51)
Complete data recorded
30 days 100% (n = 49)
Lost to follow-up (n = 0) 























Excluded (n = 1)
No surgery
(palliation)
Figure 1 Participant flow chart. TTE, transthoracic echocardigography
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deemed unfit for surgery by the treating team and pal-
liative care ensued instead of surgery. These two partici-
pants were not deemed to be protocol violations. A
participant flow chart is shown in Fig. 1.
Group baseline characteristics, comorbidities and
procedural characteristics of the 100 study participants
are shown in Table 2. The median (IQR [range]) age
of the participants was 82 (74–88 [40–98]) years
(ultrasound 82 (73–88 [47–98]) and control 83 (76–89
[40–98]) y). Pre-operative stay was 1 (1–1 [0–5]) days
(ultrasound 1 (0–1 [0–3]) and control 1 (1–1 [0–5]) d).
ASA status was 3 (3–4 [1–4]) (ultrasound 3 (3–4 [1–4])
and control 3 (3–4 [2–4])).
Pre-operative comorbidities recorded included:
ASA physical status [26]; congestive cardiac failure
[25]; ischaemic heart disease (either documented previ-
ous myocardial infarction, abnormal coronary angio-
gram or coronary revascularisation) [27]; valve disease
of at least moderate severity [20, 21]; pulmonary
hypertension (mean pulmonary artery pressure
> 25 mmHg or systolic pulmonary artery pressure
> 35 mmHg [28]); dysrhythmia (documented atrial
fibrillation, atrial flutter, ventricular tachycardia or
ventricular fibrillation [25]); cerebrovascular disease
(embolic, thrombotic or haemorrhagic cerebral event
with persistent residual motor, sensory or cognitive
dysfunction [27]); chronic obstructive pulmonary dis-
ease (use of bronchodilators or steroids [29]); diabetes
mellitus requiring oral hypoglycaemic or insulin ther-
apy [29]; renal impairment (persistent elevated crea-
tinine or requirement for intermittent peritoneal or
haemodialysis [25]); and high level of dependence on
full-time care.
Group primary and secondary outcomes are shown
in Table 3. The median (IQR [range]) length of inpa-
tient stay was 8 (6–12 [0–30]) days (ultrasound 7 (5–13
[3–30]) and control 9 (6–14 [0–30]) d). Intensive care
length of stay was 1 (1–1 [0–1]) days (ultrasound 0 (1–1
[0–1]) and control 0 (0–0 [0–0]) d). The primary com-
posite outcome at 30 days after surgery occurred in
seven of the ultrasound group patients and 12 of the
control group patients (relative group separation 39%).
Only the 30-day outcomes are reported, as the
90-day and 1-year outcome time-points have not
passed for all participants to date.
Although there were no participants recorded to
have suffered a non-fatal myocardial infarction or car-
diac arrest, two out of the three participants in the
ultrasound group that died may have been due to
myocardial infarction, as the cause of death were
recorded as myocardial infarction (pre-operative ultra-
sound revealed hypovolaemia) and cardiac failure
(ultrasound revealed aortic stenosis with left and right
ventricular failure). The cause of death in the third
ultrasound patient was unknown (ultrasound revealed
right ventricular failure, aortic and tricuspid regurgita-
tion). The cause of death in the five participants in the
control group participants was cerebrovascular acci-
dent, pulmonary embolism, surgical complications and
two unknown.
Focused cardiac ultrasound findings in the 49 par-
ticipants in the ultrasound group are shown in
Table 4. Focused cardiac ultrasound led to a change in
diagnosis in 26 and a change in management in 17 of
the ultrasound-group participants; in nine cases, ultra-
sound identified significant unexpected pathology
prompting stepped-up treatment, and in eight cases,
ultrasound excluded significant suspected pathology,
prompting stepped-down treatment (Table 5).
Table 2 Baseline characteristics, comorbidities, and







Number of participants 100 49 51
Female 70 31 39
Hypertension 55 29 26
Cardiac failure 13 7 6
Ischaemic heart disease 16 9 7
Pulmonary hypertension 1 0 1
Valve disease 6 1 5
Cardiac dysrhythmia 35 18 17




Diabetes mellitus 15 9 6
Renal impairment 3 1 2
High level of dependence 22 11 11
Surgery type
Dynamic hip screw 39 21 18
Proximal femoral nail 28 13 15
Hemi-arthroplasty 26 10 16
Total hip replacement 7 5 2
Anaesthesia type
General anaesthesia 85 48 37
Regional anaesthesia 15 1 14
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Discussion
This one-year pilot study comparing 30-day outcomes
between hip fracture patients receiving or not receiving
pre-operative focused cardiac ultrasound indicates that
a larger, definitive study is feasible. The study achieved
its aims, achieving a mean (SD) screening:recruitment
ratio of 1.7 (0.2) and a mean recruitment rate of at least
2.2 patients.week1 in the four participating hospitals,
with only 1 out of 102 protocol violations, and group
separation for the primary outcome of ≥ 20% (39%).
Focused cardiac ultrasound did not appear to delay sur-
gery and changed diagnosis and/or management in
≥ 25% (53% and 35%, respectively) of participants.
Based on a more conservative effect size of the pri-
mary outcome of 25% (39% in this pilot study) and con-
trol group incidence of primary outcome of 12 out of
51, using a two-tailed design, alpha of 0.05 and power of
0.9, a sample size of 984 participants per group will be
required, which will be rounded up to 1000 participants
in each group to account for attrition other than that
caused by death. Using a conservative recruitment rate
of one participant per site per week, to complete the
trial in three years will require 13 sites.
The primary outcome was designed to detect com-
plications that could be primarily related to cardiac
pathology, although other non-cardiac complications
(such as pneumonia) could be indirectly influenced by
Table 3 Group primary and secondary outcomes. Values are number.
Total Ultrasound group Control group Odds ratio 95%CI
Primary outcome
Composite at 30 days 19 7 12 0.54 0.19–1.52
Secondary outcomes
Mortality < 30 days 8 3 5 0.60 0.14–2.66
Morbidity < 30 days 11 4 7 0.56 0.15–2.04
Pulmonary embolus 4 2 2 1.04 0.14–7.71
Acute kidney injury (RIFLE 1) 6 1 5 0.19 0.02–1.70
Cardiac arrest 0 0 0 – –
Cerebrovascular accident 1 1 0 – –
Acute myocardial infarction 0 0 0 – –
Congestive cardiac failure 8 0 8 – –
New cardiac dysrhythmia 8 3 5 0.60 0.14–2.66
Respiratory failure 10 4 5 0.70 0.21–3.24
Pneumonia 15 4 11 0.32 0.10–1.10
Pulmonary aspiration 3 0 3 – –
Pleural effusion(s) 8 2 6 0.32 0.06–1.67
Bronchospasm 1 0 1 – –
Pneumothorax 0 0 0 – –
Infection – uncertain origin 2 1 1 1.00 0.06–17.1
Infection – superficial surgical site 0 0 0 – –
Infection – deep surgical site 0 0 0 – –
Urinary tract infection 21 10 11 0.93 0.36–2.44
Table 4 Focused cardiac ultrasound findings in 48
participants. Valve pathology indicates at least moder-
ate stenosis or regurgitation according to recognised







Systolic + diastolic dysfunction 2
RV dysfunction 1




Isolated aortic stenosis 2
Aortic stenosis + ventricular dysfunction 4
Tricuspid regurgitation 4
Mitral regurgitation 1
LV, left ventricle; RV, right ventricle.
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cardiac disease, such as pulmonary venous congestion.
Death was the most common contributor to the pri-
mary outcome, and group separation (point estimates)
occurred in favour of the ultrasound group. Of note,
the cardiac pathology identified on focused cardiac
ultrasound in the three ultrasound participants who
died was very severe, and death may have been
unavoidable. One of the secondary aims of the proposed
definitive trial will be to identify patterns of cardiac
pathology where death is inevitable, prompting non-
operative management. This may assist in end-of-life
decisions including whether or not to proceed with sur-
gery if it is deemed futile from the ultrasound findings.
Composite end-points consisting of binary events
are frequently chosen as the primary outcome in medi-
cal trials of this nature and size, because no single out-
come fully characterises the disease or outcome of
interest and individual outcomes may occur rarely,
Table 5 Stepped-up/down treatment changes after rediagnosis using focused cardiac ultrasound.
Clinical findings Change in diagnosis from ultrasound Change in management
Significant unexpected pathology
diagnosed + treatment stepped-up
Normal Alerted to aortic stenosis, LV systolic and
diastolic dysfunction, RV dysfunction,
tricuspid regurgitation and PHT
Change from spinal anaesthesia to
general anaesthesia. Insertion of
arterial catheter and commencement
of vasopressor infusion before
anaesthesia.
Normal Alerted to vasodilation Change from spinal anaesthesia to
general anaesthesia. Commencement
of vasopressor infusion before
anaesthesia
Normal Alerted to aortic stenosis and LV
diastolic dysfunction
Vasopressor and inotrope infusions
Normal Alerted to hypovolaemia, mitral and
tricuspid regurgitation
Fluids given before anaesthesia
Normal Alerted to LV diastolic dysfunction, mitral
and tricuspid regurgitation and PHT
Less fluids given than planned
Normal Alerted to tricuspid regurgitation Less fluids given than planned
AS, MR, LV + RV systolic dysfunction Alerted to PHT, confirmed LV and RV
systolic dysfunction, reassured no
aortic stenosis or MR
Delay surgery for haemodialysis
LV+RV systolic+diastolic dysfunction Alerted to aortic stenosis, confirmed LV
and RV systolic and diastolic dysfunction
ICU postoperatively
LV systolic dysfunction Alerted to right ventricular dysfunction,
aortic and tricuspid regurgitation.
Reassured no LV systolic dysfunction
Less fluids given
Significant pathology excluded,
and treatment stepped down
LV + RV systolic and diastolic
dysfunction, aortic regurgitation
Reassured absence of RV failure and
aortic regurgitation
No inotrope used
LV systolic dysfunction Reassured absence of LV systolic dysfunction More fluids given than planned
LV systolic dysfunction and
hypovolaemia
Reassured absence of LV systolic dysfunction More fluids given than planned
Pulmonary embolus and right
ventricular dysfunction
Reassured absence of pulmonary embolus
and right ventricular dysfunction. Alerted
to LV diastolic dysfunction and
pericardial effusion
More fluids given than planned
AS and regurgitation Reassured absence of aortic regurgitation More fluids given than planned
Hypovolaemia Reassured absence of hypovolaemia No fluids given before anaesthesia
Hypovolaemia and LV
systolic dysfunction
Reassured absence of hypovolaemia and
LV systolic dysfunction
Less fluids given than planned
AS and MR Reassured absence of AS No vasopressor infusion used
Valve pathology indicates at least moderate stenosis or regurgitation according to recognised guidelines [20, 21].
ICU, intensive care unit; LV, left ventricle; RV, right ventricle; PHT, pulmonary hypertension; AS, aortic stenosis; MR, mitral
regurgitation.
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therefore, the statistical power may be inadequate for
any single outcome (e.g. death) [30]. This was found
in our pilot study, where the prevalence of the com-
posite outcome (19) was more than double that of
mortality alone (8). For these reasons, chose a mortal-
ity and morbidity composite outcome based on the
ENIGMA-2 trial [24], which involved patients at
increased risk of cardiac disease undergoing non-car-
diac surgery [24], representing a group with similar
comorbid characteristics to the hip fracture population.
We added mild acute kidney injury, as this occurs
commonly and is associated with adverse outcomes
after hip fracture surgery [31]. Non-fatal myocardial
infarction and non-fatal cardiac arrest were not
recorded in either group, although myocardial infarc-
tion was reported as the cause of death in two partici-
pants and cardiac failure in one participant. We accept
that our pilot study may have missed episodes of non-
fatal myocardial infarction, the detection of which we
hope to improve in the proposed larger trial by using
serial serum troponin and ECG measurement.
Given the considerable financial burden of in-
patient care for hip fracture patients, we intend to
investigate the cost implications of assessing patients
using ultrasound compared with conventional assess-
ment. Focused cardiac ultrasound incurs additional
costs, related to capital purchase and maintenance,
training, process time and care expansion (e.g. inten-
sive care provision, additional surgery such as valve
replacement), which may be balanced by financial sav-
ings consequent to complication rates, duration of
inpatient stay and quality of life after hospital dis-
charge.
This pilot study suggests that a larger, definitive
randomised controlled trial is feasible; recruitment
rates were achievable, protocol violations were rare
and group separation of the primary, composite end-
point was achieved. Focused cardiac ultrasound did
not appear to delay surgery and changed diagnosis
and/or management in ≥ 25% (26 out of 49 and 17
out of 49, respectively) of participants. Based on a
sample size of 2000 participants in 13 hospitals over
three years, we estimate the definitive trial would cost
an estimated AU$ 2.5 million (~£1.54 million,
€1.67 million, US$ 2 million) to conduct.
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